Cell MedX (CMXC) Stock Price, News & Analysis

Company Overview

Cell MedX Corp., a biotech company, discovers, develops, and commercializes therapeutic and non-therapeutic products for patients with diabetes, Parkinson's disease, high blood pressure, neuropathy, and kidney functions in the United States. The company develops and manufactures eBalance Pro System for professional use by healthcare practitioners in a clinical setting; and eBalance Home System for home use for general wellness and pain management treatment, which are controlled by the eBalance Console that acts as the central controller for three pre-programmed microcurrent algorithms, including wellness, pain management, and dual. It also develops eBalance Home and eBalance Pro System for temporary relief of shoulder, waist, back, neck, arms, and legs. The company was formerly known as Sports Asylum, Inc. and changed its name to Cell MedX Corp. in September 2014. Cell MedX Corp. was incorporated in 2010 and is headquartered in Carson City, Nevada.

Key Stats

• Today's Range: $0.39 to $0.39
• 50-Day Range: $0.22 to $0.47
• 52-Week Range: $0.00 to $0.23
• Volume: 67 shs
• Average Volume: 20,342 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

CMXC Stock Analysis - Frequently Asked Questions

How have CMXC shares performed this year?

Cell MedX's stock was trading at $0.4899 at the beginning of 2025. Since then, CMXC shares have decreased by 20.9% and is now trading at $0.3873.
View the best growth stocks for 2025 here.

How do I buy shares of Cell MedX?

Shares of CMXC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Cell MedX own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Cell MedX investors own include Callon Petroleum (CPE), Ashford Hospitality Trust (AHT), Peabody Energy (BTU), Himax Technologies (HIMX), Remark (MARK), MicroVision (MVIS) and Ritter Pharmaceuticals (RTTR).

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Medical Devices
• Sub-Industry: Retail
• Current Symbol: OTCMKTS:CMXC
• Previous Symbol: NASDAQ:CMXC
• CIK: 1493712
• Web: cellmedx.com
• Phone: (844) 238-2692
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A